Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001001332 | SCV001158521 | uncertain significance | Elliptocytosis 1 | 2019-06-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002549160 | SCV003526011 | uncertain significance | Inborn genetic diseases | 2024-09-10 | criteria provided, single submitter | clinical testing | The c.560A>G (p.Y187C) alteration is located in exon 9 (coding exon 6) of the EPB41 gene. This alteration results from a A to G substitution at nucleotide position 560, causing the tyrosine (Y) at amino acid position 187 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |